Data Foundry

Medical device recalls 2023

Hemopro 2 with Vasoshield — Class II medical device recall Z-0995-2023

Ongoing recall by Maquet Cardiovascular, LLC, reported 2023-01-25, distributed nationwide. Ink on the Vasoshield syringe Maquet logo may chip resulting in an unreasonable risk of harm to the patient. P

Recall numberZ-0995-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmMaquet Cardiovascular, LLC, Wayne, NJ, United States
Recall initiated2022-12-22
Classified2023-01-19
Reported by FDA2023-01-25
DistributedNationwide (US)
Countries outside the USDE, JP
Quantity9,817 devices
Reason classesforeign material
UPC / GTIN / UDI-DI00607567700901
Serial numbers25152107, 25152204, 25152293, 25152463, 25152771, 25153153, 25153273, 25153366, 25153585, 25153847, 25153960, 25154066, 25154880, 25155262, 25155326, 25155785, 25156245, 25156642, 25157016, 25157085, 25157244, 25157700, 25157898, 25158066, 25158152 and 24 more
Model numbersVH-4001

Product

Hemopro 2 with Vasoshield, Model VH-4001

Reason for recall

Ink on the Vasoshield syringe Maquet logo may chip resulting in an unreasonable risk of harm to the patient. Potential harms may include foreign body reaction, coronary embolic event, and peripheral embolic event.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0995-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.